SCHEMBL9899665

SCHEMBL9899665

O=c1[nH]c(=O)c2[nH]c(-c3c[nH]nn3)nc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 2/20 0.53
MAPT P10636 2/20 0.41
ACHE P22303 1/20 0.38
GDA Q9Y2T3 1/20 0.38
XDH P47989 4/20 0.37
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
ADORA2A P29274 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA1 P30542 1/20 0.32
BLM P54132 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
PABPC1 P11940 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19066331 0.72 ADORA2B (0.60) ADORA2BMAPTACHEGDAXDH
SCHEMBL378879 0.69 ADORA2B (1.00) ADORA2BMAPTXDHALDH1A1HPGD
SCHEMBL9253425 0.65 ADORA2B (0.59) ADORA2BMAPTALDH1A1HSD17B10HPGD
SCHEMBL18036538 0.65 ADORA2B (0.63) ADORA2BXDHALDH1A1HSD17B10HPGD
SCHEMBL27316163 0.64 ADORA2B (0.50) ADORA2BMAPTACHEGDAXDH
SCHEMBL10884191 0.64 GCK (0.32) XDH
SCHEMBL1051055 0.63 ADORA2B (0.60) ADORA2BMAPTACHEGDAXDH
SCHEMBL6796628 0.63 ADORA2B (0.64) ADORA2BXDHALDH1A1HSD17B10CYP3A4
Water SCHEMBL27847814 0.63 ADORA2B (0.49) ADORA2BMAPTACHEGDAXDH
SCHEMBL31232906 0.63 ADORA2B (0.46) ADORA2BMAPTACHEGDAXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP claimed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO claimed
EP-3226858-B1 IMIDAZOLE-BASED ANTIMICROBIAL AGENTS PROCOMCURE BIOTECH GMBH (AT) 2021-02-03 EP disclosed
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed